Clinical trial
Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma
NCT07033572 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma
- Lead sponsor
- Fujian Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2018
- Completion date
- June 30, 2028
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.